Dr. Joseph Evans shares results from a recent clinical trial showing a reduction in a key mediator of atherosclerosis after supplementation with a novel dietary fiber.

EFTR: Lowering OxLDL with a Novel Fiber

Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source.  Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease). Hosted by Mercodia.

Medicine

Natural Sciences

Learn about scientific advances that lead to a better understanding of diseases and therapies. Interviews with scientists and clinicians will provide you with cutting-edge information, coming directly from the source. Explore topics ranging from drug discovery and new FDA regulations to novel approaches to metabolic diseases (e.g., diabetes and heart disease). Hosted by Mercodia.

Share EFTR: Lowering OxLDL with a Novel Fiber

Sign up to save your podcasts

EFTR: Lowering OxLDL with a Novel Fiber

EFTR: Lowering OxLDL with a Novel Fiber